[go: up one dir, main page]

GB0329362D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0329362D0
GB0329362D0 GBGB0329362.8A GB0329362A GB0329362D0 GB 0329362 D0 GB0329362 D0 GB 0329362D0 GB 0329362 A GB0329362 A GB 0329362A GB 0329362 D0 GB0329362 D0 GB 0329362D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0329362.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0329362.8A priority Critical patent/GB0329362D0/en
Publication of GB0329362D0 publication Critical patent/GB0329362D0/en
Priority to PCT/EP2004/014469 priority patent/WO2005058882A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0329362.8A 2003-12-18 2003-12-18 Compounds Ceased GB0329362D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0329362.8A GB0329362D0 (en) 2003-12-18 2003-12-18 Compounds
PCT/EP2004/014469 WO2005058882A1 (en) 2003-12-18 2004-12-16 Compounds having morpholinyl and piperidinyl groups for use as glyt1 and glyt2 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0329362.8A GB0329362D0 (en) 2003-12-18 2003-12-18 Compounds

Publications (1)

Publication Number Publication Date
GB0329362D0 true GB0329362D0 (en) 2004-01-21

Family

ID=30471322

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0329362.8A Ceased GB0329362D0 (en) 2003-12-18 2003-12-18 Compounds

Country Status (2)

Country Link
GB (1) GB0329362D0 (en)
WO (1) WO2005058882A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0606730A2 (en) * 2005-01-18 2009-07-14 Hoffmann La Roche 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
ATE447572T1 (en) 2005-01-26 2009-11-15 Hoffmann La Roche PHENYLMETHANONE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORTER-1 INHIBITORS
HRP20100076T1 (en) 2005-02-07 2010-03-31 F. Hoffmann - La Roche Ag Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
WO2006110724A2 (en) * 2005-04-11 2006-10-19 Yale University Method of treating schizophrenia prodrome
US8519026B2 (en) 2006-12-28 2013-08-27 Nuplex Resins B.V. Waterborne polymeric dispersions
CN101784533B (en) 2007-08-22 2013-08-21 艾博特股份有限两合公司 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
ES2397764T3 (en) 2008-04-01 2013-03-11 Abbott Gmbh & Co. Kg Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
AR075442A1 (en) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY
TW201038569A (en) 2009-02-16 2010-11-01 Abbott Gmbh & Co Kg Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) * 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en) 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8853196B2 (en) 2011-08-05 2014-10-07 AbbVie Deutschland GmbH & Co. KG Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
CA2853254A1 (en) 2011-11-18 2013-05-23 Abbvie Inc. N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2016004936A (en) 2013-10-17 2016-12-20 Abbvie Deutschland Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquin oline derivatives, pharmaceutical compositions containing them, and their use in therapy.
CA2924699A1 (en) 2013-10-17 2015-04-23 AbbVie Deutschland GmbH & Co. KG Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9550754B2 (en) 2014-09-11 2017-01-24 AbbVie Deutschland GmbH & Co. KG 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130696D0 (en) * 2001-12-21 2002-02-06 Smithkline Beecham Plc Chemical Compounds

Also Published As

Publication number Publication date
WO2005058882A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
GB0316915D0 (en) Compounds
GB0309781D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0329362D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0317498D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0302512D0 (en) Compounds
GB0304494D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0310851D0 (en) Compounds
GB0314698D0 (en) Compounds
GB0308105D0 (en) Compounds
GB0308017D0 (en) Compounds
GB0310065D0 (en) Compounds
GB0307998D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)